Bakkt Holdings, Inc. (BKKT)

Investigation 

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT). The investigation concerns whether Bakkt and certain of its officers and/or directors have violated federal securities laws.

 

On November 22, 2021, in a filing with the U.S. Securities and Exchange Commission, Bakkt disclosed that the Company’s management “has re-evaluated the application of ASC 480-10-S99-3A to the accounting classification of the Class A ordinary shares, par value $0.0001 (the “Class A Ordinary Shares”) of VPC Acquisition Impact Holdings (“VIH”) . . . which were issued in connection with VIH’s initial public offering (the “IPO”), and has identified errors in the historical financial statements of VIH . . . related to the misclassification (the “Misclassification”) of the Class A Ordinary Share” and “has determined that it is appropriate to restate certain of VIH’s condensed consolidated financial statements[.]”  On this news, Bakkt’s stock price fell sharply during intraday trading on November 22, 2021.

 

If you are aware of any facts relating to this investigation or purchased Bakkt shares, you can assist this investigation. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.